Real-time enrollment status for this aml clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT03926624 |
| Recruiting Status | Terminated |
| Condition | AML |
| Phase | Clinical Trial |
| Target Enrollment | 450 participants |
| Active Locations | 39 sites in the US |
| Sponsor | Delta-Fly Pharma, Inc. |
| Last Updated on CT.gov | January 22, 2026 (Jan 22, 2026) |
As of March 2, 2026: Clinical trial NCT03926624 is currently terminated participants. This clinical trial study for aml is not currently accepting new participants at 39 locations across the United States. The study is sponsored by Delta-Fly Pharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03926624 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 39 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03926624 was last updated Jan 22, 2026 (January 22, 2026). HelloStudys verifies this status automatically.